YZOFF yields 3.66% · PFE yields 6.13%● Live data
📍 YZOFF pulled ahead of the other in Year 1
Combined, YZOFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YZOFF + PFE for your $10,000?
Yangtze Optical Fibre And Cable Joint Stock Limited Company researchs, develops, produces, and sells optical fiber and cable products in the People's Republic of China and internationally. The company operates in two segments, Optical Fibres and Optical Fibre Preforms, and Optical Fibre Cables segments. It also provides copper wire and related products; integrated wiring systems; technical development consulting services for computer hardware and software and ancillary equipment; and vapor and chemical raw materials. In addition, the company imports, exports, and sells submarine cables, optical cables, and other power cables and their accessories, as well as trades in raw materials; and installs cables, accessories, and systems related to various submarine projects. Further, it designs, produces, and sells optical communication equipment and electrical products, as well as provides integrated services in communication, computer, intelligent building, weak current system, and software development. Additionally, the company engages in research and promotion of medical materials, as well as provides general contracting engineering services. Yangtze Optical Fibre And Cable Joint Stock Limited Company was founded in 1988 and is headquartered in Wuhan, the People's Republic of China.
Full YZOFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.